LOS ANGELES, Calif. (PRWEB) November 22, 2017
One of the world’s most sought after specialists in the advancement of spinal health for nearly three decades, Beverly Hills-based spinal neurosurgeon Dr. Todd Lanman was invited earlier this month to help support Medtronic’s efforts in facilitating motion preservation surgery with artificial disc replacements.
The largest medical equipment development company, Medtronic, which is well known for being the manufacturer of the Prestige LP, a revolutionary two-level Artificial Cervical Disc device, asked Dr. Lanman to help develop strategies and educate more than 300 of their representatives from around the country with techniques to assist them with interfacing with surgeons in order to simplify installations of discs in their patients.
As the principal investigator on the 10-year-long clinical trial of the now FDA-approved Artificial Cervical Disc Replacement procedure using the Prestige LP device, Lanman presented key points and findings from his 7-year follow up for Medtronic’s team of representatives to use while working with surgeons and patients.
Some of these included noting statistical superiority with neck pain, arm pain, neurologic outcomes and overall success with the device, comparing all against that of fusion in two adjacent disc levels in the neck.
Dr. Lanman then spent the remainder of the televised conference answering questions from Medtronic’s team as it related to Artificial Disc Replacements in the cervical spine.
Recently, Lanman launched The Lanman Foundation for Spinal Advancement and Innovative Health (http://www.LanmanFoundation.com), his new organization and initiative focused on leading the way for innovation in spine health and motion preserving spinal technologies. His namesake charitable endeavor also assists with supporting U.S. military veterans injured during active duty.
Lanman Spinal Neurosurgery is affiliated with Cedars-Sinai Medical Center’s Institute for Spinal Disorders, UCLA Medical Center and Saint John’s Medical Center.